Updated April 25 at 4:56pm
Biotechnology
39 results total, viewing 11 - 20
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
MultiCell Technologies Inc. has been issued a U.S. patent for drug compositions and platform technologies, which are designed treat virus infections and cancer. more
Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien PLC for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Nabsys Inc. has begun a search for CEO candidates with experience in life sciences commercialization, as the company moves closer to bringing its high-speed DNA sequencing technology to market, current CEO Dr. Barrett Bready told Providence Business News. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
« Prev | 1 | 2 | 3 | 4 Next »